Growth of Infants Fed an Elemental Medical Food
1 other identifier
interventional
213
1 country
2
Brief Summary
Effects on weight will be monitored in healthy infant subjects consuming assigned infant formulas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Apr 1999
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2000
CompletedFirst Submitted
Initial submission to the registry
October 2, 2012
CompletedFirst Posted
Study publicly available on registry
October 3, 2012
CompletedOctober 3, 2012
October 1, 2012
1.7 years
October 2, 2012
October 2, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Weight
weight gain during the study period
14 days of age to 112 days of age
Secondary Outcomes (3)
Anthropometric Measurements
14 days of age to 112 days of age
GI Tolerance
At visits 14 and 28
Lab Measurement
At 112 day visit
Study Arms (2)
Control Study Formula
ACTIVE COMPARATORprotein hydrolysate formula
Experimental Study Formula
EXPERIMENTALfree-amino acid-based medical food
Interventions
feed as lib
feed as lib
Eligibility Criteria
You may qualify if:
- Singleton, healthy infant
- Gestational age of 37 to 42 weeks
- Birth weight of 2500 grams or greater
- Age between birth and 9 days of age
- Parents agree to not administer mineral or vitamin supplements during the study period
- Parents agree to feed study formula exclusively for the duration of the study
You may not qualify if:
- Maternal, fetal or perinatal history which may have adverse effects on growth
- Multiple birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (2)
T&W Research
Little Rock, Arkansas, 72211, United States
University of Iowa
Iowa City, Iowa, 52242-1083, United States
Related Publications (1)
Amari S, Shahrook S, Namba F, Ota E, Mori R. Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates. Cochrane Database Syst Rev. 2020 Oct 2;10(10):CD012273. doi: 10.1002/14651858.CD012273.pub2.
PMID: 33006765DERIVED
MeSH Terms
Interventions
Study Officials
- STUDY CHAIR
Marlene W Borschel, PhD, RD
Abbott Nutrition
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2012
First Posted
October 3, 2012
Study Start
April 1, 1999
Primary Completion
December 1, 2000
Study Completion
December 1, 2000
Last Updated
October 3, 2012
Record last verified: 2012-10